Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells

Biocell

Volumn 35, Issue 3, 2011, Pages 71-79

  Liu, Qingxin ^a   Chen, Xianggui ^b   Yang, Guolin ^a   Min, Xuewen ^c   Deng, Maoxian ^a  

^a Jiangsu Polytechnic College of Agriculture and Forestry   (China)

^b XIHUA UNIVERSITY   (China)

^c People's Hospital of Jurong   (China)

Author keywords

Cell motility; Flavonoid; MAP kinase

Indexed keywords

APIGENIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ACTIN POLYMERIZATION; ADENOVIRUS INFECTION; ARTICLE; BLADDER; BLADDER CANCER; CANCER TISSUE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MIGRATION INHIBITION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; TRANSIENT EXPRESSION;

ADENOVIRIDAE; ANIMALS; APIGENIN; CELL MOVEMENT; CELLS, CULTURED; HUMANS; IMMUNOBLOTTING; MAP KINASE KINASE KINASE 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; URINARY BLADDER;

MURINAE;

EID: 84859046915     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ajay M, Gilani AU, Mustafa MR (2003). Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Science 5: 603-612.
2. Capasso R, Fiorino F, Ascione V, Frecentese F, Borrelli F (2006). Inhibition of rat vas deferens contractions by flavonoids in vitro. Journal of Pharmacy and Pharmacology 58: 381-384.
3. Chuang CM, Monie A, Wu A, Hung CF (2009). Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. Journal of Biomedical Science 16: 49.
4. Franzen CA, Amargo E, Todorovic V, Desai B V, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC (2009). The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prevention Research (Phila) 2: 830-841.
5. Frigo DE, Duong BN, Melnik LI, Schief LS, Collins-Burow BM, Pace DK, McLachlan JA, Burow ME (2002). Flavonoid phytochemicals regulate activator protein 1 signal transduction pathways in endometrial and kidney stable cell lines. The Journal of Nutrition 132: 1848-1853.
6. Gharzouli K, Holzer P (2004). Inhibition of guinea pig intestinal peristalsis by the flavonoids quercetin, naringenin, apigenin and genistein. Pharmacology 70: 5-14.
7. He TC, Zhou S, da Costa LT, Yu J, Kinzler K W, Vogelstein B (1998). A simplified system for generating recombinant adenoviruses. Proceedings of the National Academy of Sciences of the United States 95: 2509-2514.
8. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Weber LA, Gerthoffer WT (1999). A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. The Journal of Biological Chemistry 274: 24211-24219.
9. Henkels KM, Frondorf K, Gonzalez-Mejia ME, Doseff AL, Gomez-Cambronero J (2010). IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3). FEBS Letters 585: 159-166.
10. Hu X W, Meng D, Fang J (2008). Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 29: 2369-2376.
11. Jeong GS, Lee SH, Jeong SN, Kim YC, Kim EC (2009). Anti-inflammatory effects of apigenin on nicotine- and lipopolysac-charide-stimulated human periodontal ligament cells via heme oxygenase-1. International Immunopharmacology 9: 1374-1380.
12. Kim BR, Jeon YK, Nam MJ (2011). A mechanism of apigenin-in-duced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells. Food and Chemical Toxicology 47: 1626-1632.
13. Kim TJ, Zhang YH, Kim Y, Lee CK, Lee MK, Hong JT, Yun YP (2002). Effects of apigenin on the serum- and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Medica 68: 605-609.
14. Kim DI, Lee TK, Lim IS, Kim H, Lee YC, Kim CH (2005). Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds. Toxicology and Applied Pharmacology 205: 213-224.
15. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA (1997). Regulation of cell motility by mitogen-activated protein kinase. The Journal of Cell Biology 137: 481-492.
16. Kuo ML, Yang NC (1995). Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochemical and Biophysical Research Communications 212: 767-775.
17. Lamy S, Bedard V, Labbe D, Sartelet H, Barthomeuf C, Gingras D, Beliveau R (2008). The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation. Cancer Prevention Research (Phila Pa) 1: 452-459.
18. Lauffenburger DA, Horwitz AF (1996). Cell migration: a physically integrated molecular process. Cell 84(3): 359-369.
19. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH (2008). Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology 226: 178-191.
20. Li ZD, Hu X W, Wang YT, Fang J (2009). Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett 583: 1999-2003.
21. Long X, Fan M, Bigsby RM, Nephew KP (2008). Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Molecular Cancer Therapeutics 7: 2096-2108.
22. Morello S, Vellecco V, Alfieri A, Mascolo N, Cicala C (2006). Vasorelaxant effect of the flavonoid galangin on isolated rat thoracic aorta. Life Science 78: 825-830.
23. Mounho BJ, Thrall BD (1999). The extracellular signal-regulated kinase pathway contributes to mitogenic and anti-apoptotic effects of peroxisome proliferators in vitro. Toxicology and Applied Pharmacology 159: 125-133.
24. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL (1999). Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. The Journal of Cell Biology 146: 149-164.
25. Noh HJ, Sung EG, Kim, JY, Lee TJ, Song IH (2010). Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-acti-vated protein kinase-dependent matrix metalloproteinase-9 expression. Oncology Reports 24: 277-283.
26. Rotondo A, Serio R, Mule F (2009). Gastric relaxation induced by apigenin and quercetin: analysis of the mechanism of action. Life Science 85: 85-90.
27. Rousseau S, Houle F, Landry J, Huot J (1997). p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothe-lial cells. Oncogene 15: 2169-2177.
28. Rousseau S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nebreda AR, Arthur JS, Case LM, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P (2006). CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal 18: 1897-1905.
29. Sarkar FH, Li Y (2004). Cell signaling pathways altered by natural chemopreventive agents. Mutation Research 555: 53-64.
30. Van Dross R, Xue Y, Knudson A, Pelling JC (2003). The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. The Journal of Nutrition 133 (11 Suppl 1): 3800S-3804S.
31. Xia Y, Karin M (2004). The control of cell motility and epithelial morphogenesis by Jun kinases. Trends in Cell Biology 14: 94-101.
32. Yin F, Giuliano AE, Van Herle AJ (1999). Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Research 19: 4297-4303.
33. Yin F, Giuliano AE, Law RE, Van Herle AJ (2001). Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Research 21: 413-420.
34. Yousufzai SY, Gao G, Abdel-Latif AA (2000). Mitogen-activated protein kinase inhibitors suppress prostaglandin F(2alpha)-induced myosin-light chain phosphorylation and contraction in iris sphincter smooth muscle. European Journal of Pharmacology 407: 17-26.
35. Zeigler ME, Chi Y, Schmidt T, Varani J (1999). Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. Journal of Cellular Physiology 180: 271-284.
36. Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD, Zheng Y, Xia Y (2005). MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Molecular and Cellular Biology 25: 60-65.
37. Zou Y, Chiou GC (2006). Apigenin inhibits laser-induced choroidal neovascularization and regulates endothelial cell function. Journal of Ocular Pharmacology and Therapeutics 22: 425-430.